Imazodan | CAS# 84243-58-3 | Biochemical

MedKoo Cat#: 576612 | Name: Imazodan

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Imazodan is a type III phosphodiesterase inhibitor that may be useful in the treatment of congestive heart failure.

Chemical Structure

Imazodan

CAS#84243-58-3

Theoretical Analysis

MedKoo Cat#: 576612

Name: Imazodan

CAS#: 84243-58-3

Chemical Formula: C13H12N4O

Exact Mass: 240.1011

Molecular Weight: 240.27

Elemental Analysis: C, 64.99; H, 5.03; N, 23.32; O, 6.66

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Imazodan

IUPAC/Chemical Name

3(2H)-Pyridazinone, 4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl)-

InChi Key

VXMYWVMXSWJFCV-UHFFFAOYSA-N

InChi Code

InChI=1S/C13H12N4O/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17/h1-4,7-9H,5-6H2,(H,16,18)

SMILES Code

O=C1CCC(=NN1)c2ccc(cc2)n3ccnc3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 240.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Goldberg AD, Nicklas J, Goldstein S. Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group. Am J Cardiol. 1991 Sep 1;68(6):631-6. doi: 10.1016/0002-9149(91)90356-p. PMID: 1715125. 2. Weishaar RE, Kobylarz-Singer D, Klinkefus BA. New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan. Cardiovasc Drugs Ther. 1989 Mar;3(1):29-42. doi: 10.1007/BF01881527. PMID: 2487522.